Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00666302 · ClinicalTrials.gov registry record · Phase 4
A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis
A Phase 4 study, sponsored by Astellas Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 413
- Enrollment target
NCT00666302: Completed Phase 4 study, sponsored by Astellas Pharma.
NCT00666302 is a Phase 4 study that has completed, run by Astellas Pharma. The registered enrollment target is 413 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (20% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00666302, a Phase 4 study, has completed, sponsored by Astellas Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 413 participants
- Enrollment target
Study Summary
A study to compare efficacy of Protopic Ointment to that of Elidel Cream in treating patients with Atopic Dermatitis
Interventions
- DRUG tacrolimus ointment
- DRUG pimecrolimus cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2002-10 |
| Est. Completion | 2003-11 |
| Phase | Phase 4 |
What the finished NCT00666302 record still lists
NCT00666302 is an interventional study that assigns participants to a tested intervention. The registered 413 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (20% lower).
The record links to 0 conditions, and to 2 interventions - of which tacrolimus ointment is the first listed.
NCT00666302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00666302 about?
NCT00666302 is a clinical study titled "A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis". A study to compare efficacy of Protopic Ointment to that of Elidel Cream in treating patients with Atopic Dermatitis
What is the current status of trial NCT00666302?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 413 participants. The study started on 2002-10. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00666302?
The interventions under investigation include: tacrolimus ointment (DRUG), pimecrolimus cream (DRUG).
Who is sponsoring clinical trial NCT00666302?
This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00666302's enrollment target sits among peer trials
413 205th of 2000 higher than 1,796 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia